| Product NDC: | 0002-1407 |
| Proprietary Name: | Quinidine Gluconate |
| Non Proprietary Name: | Quinidine Gluconate |
| Active Ingredient(s): | 80 mg/mL & nbsp; Quinidine Gluconate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0002-1407 |
| Labeler Name: | Eli Lilly and Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA007529 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19510301 |
| Package NDC: | 0002-1407-01 |
| Package Description: | 10 mL in 1 VIAL (0002-1407-01) |
| NDC Code | 0002-1407-01 |
| Proprietary Name | Quinidine Gluconate |
| Package Description | 10 mL in 1 VIAL (0002-1407-01) |
| Product NDC | 0002-1407 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Quinidine Gluconate |
| Dosage Form Name | SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19510301 |
| Marketing Category Name | NDA |
| Labeler Name | Eli Lilly and Company |
| Substance Name | QUINIDINE GLUCONATE |
| Strength Number | 80 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Antiarrhythmic [EPC],Cytochrome P450 2D6 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA] |